13F Pro

SEC Form 4 reporting owner

Mortimer Ian

Mortimer Ian has filed 21 Form 4 transactions reported between January 2, 2026 and March 13, 2026, as PRESIDENT & CEO of Xenon Pharmaceuticals Inc..

Name as filed: MORTIMER IAN

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$15.1M
12 lines
Companies
1
with Form 4 filings
Latest transaction
Mar 13, 2026
transaction date

Roles and reported holdings

  • XENEXenon Pharmaceuticals Inc.
    Jan 2, 2026 – Mar 13, 2026

    PRESIDENT & CEO

    Held directly19,923 sh as of Mar 13, 2026 · Form 4

    24 months: $15.1M sold

Transaction history

All 21 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Mar 13, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct7,308$404K@ $55.23Form 4
Mar 12, 2026XENEPRESIDENT & CEOOption exerciseCode M · direct12,500—Form 4
Mar 10, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct11,269$677K@ $60.11Form 4
Mar 9, 2026XENEPRESIDENT & CEOOption exerciseCode M · direct20,000—Form 4
Mar 9, 2026XENEPRESIDENT & CEOOption exerciseCode M · direct65,000$614K@ $9.44Form 4
Mar 9, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct61,652$3.7M@ $60.08Form 4
Mar 9, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct43,348$2.6M@ $59.26Form 4
Mar 9, 2026XENEPRESIDENT & CEOOption exerciseCode M · direct105,000$499K@ $4.75Form 4
Mar 9, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct2,449$150K@ $61.26Form 4
Mar 9, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct10,072$609K@ $60.47Form 4
Mar 9, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct12,479$743K@ $59.50Form 4
Mar 9, 2026XENEPRESIDENT & CEOOption exerciseCode M · direct25,000$78K@ $3.10Form 4
Mar 9, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct21,515$1.3M@ $60.49Form 4
Mar 9, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct31,694$1.9M@ $59.88Form 4
Mar 9, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct21,791$1.3M@ $58.81Form 4
Mar 9, 2026XENEPRESIDENT & CEOOption exerciseCode M · direct75,000$630K@ $8.40Form 4
Jan 9, 2026XENEPRESIDENT & CEOGrant or awardCode A · direct65,000—Form 4
Jan 9, 2026XENEPRESIDENT & CEOGrant or awardCode A · direct350,000—Form 4
Jan 2, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct2,062$93K@ $44.93Form 4
Jan 2, 2026XENEPRESIDENT & CEOOpen-market saleCode S · direct37,938$1.7M@ $44.40Form 4
Jan 2, 2026XENEPRESIDENT & CEOOption exerciseCode M · direct40,000$300K@ $7.49Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.